BIBI , N, and MA MALIK. 2025. “COMPARISON OF 550MG/DAY VERSES 1100 MG/DAY RIFAXIMIN IN SECONDARY PREVENTION OF BOTH COVERT AND OVERT HEPATIC ENCEPHALOPATHY”. Pakistan Journal of Intensive Care Medicine 5 (01):71. https://doi.org/10.54112/pjicm.v5i01.71.